{"id":116690,"date":"2025-10-01T12:00:00","date_gmt":"2025-10-01T16:00:00","guid":{"rendered":"https:\/\/www.freethink.com\/?post_type=ftm_article&p=116690"},"modified":"2025-10-01T14:27:38","modified_gmt":"2025-10-01T18:27:38","slug":"the-longevity-movement","status":"publish","type":"ftm_article","link":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement","title":{"rendered":"The longevity movement is growing \u2014 but it needs to go global"},"content":{"rendered":"\n

From the moment we humans became aware of our mortality, we\u2019ve been fixated on the idea of defying it. The Bible describes patriarchs who lived for centuries, Greek mythology tells of the eternally aging Tithonus, and modern sci-fi features innumerable characters who simply refuse to die. The concept has transcended fiction into the realms of medicine, exploration, and pseudoscience. Europe\u2019s medieval alchemists spent centuries searching for an immortality-granting philosopher\u2019s stone<\/a>, Spanish explorer Juan Ponce de Le\u00f3n<\/a> hunted for a fountain of youth, and French surgeon Serge Voronoff<\/a> transplanted monkey testicles onto Parisian men in an attempt to restore their youthful vitality. <\/p>\n\n\n\n

For centuries, the quest for immortality had largely led only to dead ends, but recent discoveries in genetics and cellular biology hint that we may finally be approaching genuine progress \u2014 a shift embodied this spring at Vitalist Bay<\/a>, an eight-week longevity event in Berkeley, California. There, hundreds of prominent speakers from across the science, business, and art of longevity \u2014 including some of those at the vanguard of these breakthroughs \u2014 gathered with thousands of anti-aging enthusiasts to toss around provocative ideas for how far, and how fast, they can push human life.<\/p>\n\n\n\n

Extended warranty<\/h3>\n\n\n\n

In the Bible\u2019s book of Psalms, Moses tells his followers that “the days of our lives may come to 70 years, or perhaps 80 if our strength endures.\u201d Today, approximately three millennia later, the average human lifespan remains 72 years. Moses, God\u2019s chosen prophet, was lucky enough to last until 120, according to the book of Deuteronomy. The oldest person to ever live by modern accounting, French supercentenarian Jeanne Calment<\/a>, died in 1997 at age 122.<\/p>\n\n\n\n

Humans have made remarkable progress in extending our average lifespans by quelling the plagues that used to strike us down while we were young. Yet we have had little luck moving the needle for how and when we become old. Infant mortality rates have plummeted, fewer men and women are killed in war, famines strike the bellies of smaller portions of humanity, but we can still expect our health to rapidly deteriorate across our 70s, 80s, and 90s like clockwork, just as in the time of Moses. Our biological ceiling for life has remained stubbornly unchanging.<\/p>\n\n\n\n

Longevity advocates like science blogger Tim Urban remain optimistic that this may not always be the case. Urban has encouraged his readers to adopt the view that our bodies are simply machines, and like any other contraptions, time and use slow their processes, break down their components, and jumble the information that guides their operations. That makes aging nothing more than a challenge of restorative engineering. Researchers just need to figure out exactly what goes wrong in our bodies as we age, and then \u2014 with the right combination of money and manpower \u2014 we might be able to prevent and even reverse the degeneration. <\/p>\n\n\n\n

\u201cIt’s weird that the human body has a limit on years,\u201d Urban told me shortly after giving a Vitalist Bay main stage lecture on the peculiarity of the modern scientific age that referenced everything from AI to, of course, anti-aging research. \u201cYou can have a lot of 90-year-olds who are doing great \u2014 sharp and able \u2014 and every one of them is going to be dead in 30 years. There’s not any one of the eight billion people [on Earth] that is 160.\u201d<\/p>\n\n\n

\n
\"Two
Meme from Vitalist.io<\/figcaption><\/div><\/figure>\n<\/div>\n\n\n

While the crowds at Vitalist Bay seemed to take this biomechanical view of aging as a given, some attendees shared their frustration that the perspective has only recently punctured its way into the mainstream. \u201cWhen I came into academic gerontology, radical life extension was something that nobody in the field would ever talk about,\u201d biogerontologist Aubrey de Grey, who was among the first academics to advocate for large-scale longevity research nearly 30 years ago, told me. \u201cIf you went anywhere near that idea, you would never get funded. It’s become a more acceptable thing to talk about simply because I’ve been making such a nuisance of myself all these years.\u201d<\/p>\n\n\n\n

In addition to conducting multi-pronged laboratory anti-aging research, de Grey had dedicated time in recent decades to advocating for both the viability and moral necessity of experimentation into lifespan extension on media outlets such as <\/em>TED<\/a>, \u201c60 Minutes<\/a>,\u201d and \u201cThe Joe Rogan Experience<\/a>.\u201d Given the number of curious laypeople in attendance at Vitalist Bay, it seems his publicity work has borne fruit \u2014 multiple conference speakers gave pointed thanks to de Grey for his contributions to the field of anti-aging, both scientific and social.<\/p>\n\n\n\n

While nonchalant about his subcultural celebrity, de Grey acknowledges his role in pulling the possibility of lifespan extension closer to the mainstream. \u201cI started with the indisputable fact that the body is a machine, and that means that we should be able to extend \u2014 and indeed transcend \u2014 the warranty period of the body in just the same way that we do for any man-made machines, like cars or airplanes,\u201d he told me. \u201cIt took me a few years to realize that this was all everybody was missing from their perspective on aging. But when I did realize it, the rest was history.\u201d<\/p>\n\n\n\n

Forever on a budget<\/h3>\n\n\n\n

Based on the crowds at Vitalist Bay, longevity appears to be among the hottest topics of discourse in the Bay Area, the global epicenter for technology and innovation. At Lighthaven, the five-building campus that served as the event\u2019s setting, a who\u2019s who of popular science communicators, like de Grey and Urban, mingled with big-name biotech CEOs, curious college students, and bookish digital nomads. The tech-minded throngs debated topics like the viability of cryonics and the ethics of selling unregulated longevity drugs to your friends. <\/p>\n\n\n\n

One of the conference\u2019s most anticipated speakers was celebrity biohacker Bryan Johnson<\/a>, who had recently released a Netflix documentary centered on his multimillion-dollar supplement-fueled quest to live forever. Johnson looked like a rock star as he walked onto the Vitalist Bay campus, surrounded by a pack composed mostly of attractive women.<\/p>\n\n\n\n

But despite the growing cultural appeal of longevity science, the sum of investment flowing into the field still lags far behind what will likely be needed to make any meaningful impact on the length of our lives. \u201cEighty or so longevity startups have attracted about $10\u2013$15 billion dollars in funding \u2014 that’s still really small,\u201d Nathan Cheng, one of the two co-founders of Vitalist Bay<\/a>, grumbled from the main stage. \u201cTo give context, if you look at total startup funding for biotech from 2017 to 2021, longevity research was only about 3% of that funding.\u201d\u00a0<\/p>\n\n\n\n

This is despite aging causing more than 80% of deaths in the Western world, if one attributes age-related morbidities, like heart disease and dementia, directly to aging. \u201cThe field is just so small relative to the size of the problem we are trying to deal with,\u201d said Cheng.<\/p>\n\n\n

\n
\"A
Meme from Vitalist.io<\/figcaption><\/div><\/figure>\n<\/div>\n\n\n

For any startups lucky enough to capture a share of that shallow resource pool, though, the path to a serious medical breakthrough is beginning to peek over the horizon. \u201cI\u2019m an optimistic person,\u201d said Kristen Fortney, CEO of BioAge<\/a>, a startup using genetic data from long-living humans to develop therapies that target metabolic diseases. \u201cTen years ago, there were very few companies actually working on aging. Now there’s a real trend. People are talking about longevity.\u201d<\/p>\n\n\n\n

Just as the similarly nascent fields of AI and gene editing were ignited by the respective discoveries of transformers and CRISPR, the academic field of aging biology took off with a single watershed discovery. \u201cPre-1990s, people thought that aging was just too complicated because all these different things go wrong,\u201d said Fortney. \u201cThat tune changed a bit when Cynthia Kenyon and Gary Ruvkun showed that you could delete a single gene in a worm and double its lifespan.\u201d The worms with the induced mutation not only lived longer, but also looked younger and healthier than their nonmutated counterparts. \u201cSimple change, big result \u2014 maybe [aging is] a bit simpler than we think,\u201d said Fortney.<\/p>\n\n\n\n

Unfortunately, the worms that Kenyon and Ruvkun studied have about 100 million genomic base pairs. Humans have about 3.2 billion such pairs, and the process of transposing the duo\u2019s results to people has been sluggish, at best. \u201cThe current state of affairs is that, in 2025, we still have no approved interventions or therapies for aging,\u201d said Cheng on stage at Vitalist Bay. <\/p>\n\n\n\n

Part of this is because the talent and funding that has come into the longevity field has been neither plentiful nor evenly distributed. \u201cPartial reprogramming has definitely taken the lion\u2019s share of longevity\u2019s resources,\u201d Cheng told the Vitalist Bay audience, in reference to the process of chemically de-aging cells without reverting them all the way back into stem cells. The technique has been a hotbed of research since 2016, when scientists at the Salk Institute showed they could use it to extend the lifespans of mice<\/a> by 30%, while also ameliorating some of the rodents\u2019 physical signs of aging. The promise of this process has become a catalyst for numerous biotech startups, including Altos Labs<\/a>, Calico Labs<\/a>, and Retro Biosciences<\/a>, with funding coming from name-brand billionaires such as Jeff Bezos and Sam Altman. <\/p>\n\n\n\n

But the focus on reprogramming has left other potential age-reversal modalities almost entirely unfunded. \u201cNobody seems to really care about techniques like DNA repair or extracellular matrix,” said Cheng, referring to research that looks within the cell and beyond it, respectively. <\/p>\n\n\n\n

Apollo for aging<\/h3>\n\n\n\n

For some longevity advocates at Vitalist Bay, the scale of research required to solve aging remains far too grand for venture capital to tackle alone. \u201cI think you need government-scale investment,\u201d Andrew Steele, scientist and author of the book \u201cAgeless<\/a>,\u201d told me. \u201cWe need to put in probably tens to low hundreds of billions of dollars.\u201d <\/p>\n\n\n\n

Unsurprisingly, the US government\u2019s expenditure on aging research currently falls well short of Steele\u2019s quote. \u201cThe actual amount of government money going into aging biology is about $300 to $400 million a year,\u201d he said. \u201cThat means roughly $1 per American. Aging kills about 85% of people in the US, and yet we’re spending $1 per person per year trying to sort it out.\u201d<\/p>\n\n\n\n

\n

“What we want to do is bring people here so we can actually spark a civilizational effort, something like an Apollo program.”<\/p>\nNathan Cheng<\/cite><\/blockquote>\n\n\n\n

If $100 billion sounds like an exorbitant government price tag for an as-of-yet theoretical medical modality, the market value of doing nothing could be far more astronomical. \u201cAt the end of the day, aging is extremely costly,\u201d said Cheng, using a graph projected onto a large screen atop the Vitalist Bay main stage to back up his points. \u201cThis is a chart showing the total projected Medicare and Medicaid expenditure for treating Alzheimer’s disease, a single age-related disease. It\u2019s projected to be over a trillion dollars by 2050. There’s definitely a cost to aging.\u201d\u00a0<\/p>\n\n\n\n

The US currently wastes approximately<\/a> 10%<\/a> of its annual GDP on a whack-a-mole approach to restraining chronic, largely age-related diseases, like cancer, heart disease, and Alzheimer\u2019s. If it invested in anti-aging research, it could potentially prevent these diseases from ever infiltrating our bodies in the first place. That could not only save money in the long run, but also prevent suffering.\u00a0<\/p>\n\n\n\n

This brings us to the real purpose of Vitalist Bay and initiatives like it, which gather many of the field\u2019s most prominent voices on a single plot of land: to establish an active pro-lifespan constituency that can lobby governments to take the longevity movement seriously. \u201cWhat we want to do is bring people here so we can actually spark a civilizational effort, something like an Apollo program,\u201d said Cheng. \u201cThat’s why we’re all here today, to come together and see what we can do to actually push this forward at the highest level and make this society\u2019s number one priority.\u201d<\/p>\n\n\n\n

\u201cWe still have a long way to go to be comparable in size to something like oncology, where there’s hundreds of biotech companies and clinical programs,\u201d said Fortney. \u201cThat’s the future that I want for this space.\u201d<\/p>\n\n\n\n

“I think we need to get better as a community at talking to governments, talking to policy makers, talking to normal people, and explaining to them what longevity science is.”<\/p>Andrew Steele<\/cite><\/blockquote><\/figure>\n\n\n\n

To do that, the nascent longevity movement will need to combat widespread ambivalence toward the idea of a radically longer life \u2014 and that could prove more difficult than actually developing effective anti-aging treatment. Our most fabulous longevity narratives make for both great storytelling and a frightening prospective reality. It\u2019s likely where much of the pushback against longevity research germinates. So much of our mythmaking around longevity has framed lifespan extension not only as fantastical fiction, but also a gift that must inevitably come with a catch. Immortality cost Dorian Gray his soul. Trojan prince Tithonus got eternal life, but didn\u2019t read the fine print and was doomed to suffer frailty and illness for all of eternity.\u00a0<\/p>\n\n\n\n

Real-world examples of people pursuing a longer life don\u2019t make it seem any less out there. \u201cI think we need to get better as a community at talking to governments, talking to policy makers, talking to normal people, and explaining to them what longevity science is,\u201d Steele told me. \u201cA lot of them think it\u2019s just about billionaires trying to live forever, or they think it\u2019s about crazy biohackers taking a million supplements a day.\u201d<\/p>\n\n\n\n

According to Steele and many of the most sober minds I encountered at Vitalist Bay, real progress in longevity, when it comes, will be far less dramatic. It\u2019ll transpire in the background of our lives, creeping into our routines via our diets, daily medications, and fully forgettable outpatient procedures. It\u2019ll also be far less sudden than what we\u2019ve seen in fiction \u2014 no one is going to become immortal overnight.\u00a0<\/p>\n\n\n\n

Instead, longevity will likely come to us as imperceptibly minute additions to the average number of candles occupying our birthday cakes, the slow-growing share of children who have a chance to meet their great-grandparents, the burgeoning portion of us dying peacefully in our beds after long and largely healthy lives. If these changes do occur, we will hopefully adapt to them without fuss or even without notice.<\/p>\n\n\n\n

And then, one day in the future, our descendants might look back on those of us living today and wonder why more of us weren\u2019t at Vitalist Bay, fighting for our chance to live as long as they do.<\/p>\n\n\n\n

We\u2019d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at tips@freethink.com<\/a>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Progress in longevity is real, but experts say the field needs government funding, policy reform, and public buy-in to reach its potential.<\/p>\n","protected":false},"author":25,"featured_media":116775,"template":"","ftm_taxonomy_fields":[264,57],"ftm_taxonomy_challenges":[],"ftm_taxonomy_statuses":[],"ftm_taxonomy_hidden_tags":[],"class_list":["post-116690","ftm_article","type-ftm_article","status-publish","has-post-thumbnail","hentry","ftm_taxonomy_fields-aging","ftm_taxonomy_fields-biology"],"acf":[],"apple_news_notices":[],"yoast_head":"\nThe longevity movement is growing \u2014 but it needs to go global<\/title>\n<meta name=\"description\" content=\"Progress in longevity is real, but experts say the field needs government funding, policy reform, and public buy-in to reach its potential.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.freethink.com\/biotech\/the-longevity-movement\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The longevity movement is growing \u2014 but it needs to go global\" \/>\n<meta property=\"og:description\" content=\"Progress in longevity is real, but experts say the field needs government funding, policy reform, and public buy-in to reach its potential.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.freethink.com\/biotech\/the-longevity-movement\" \/>\n<meta property=\"og:site_name\" content=\"Freethink\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T18:27:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.freethink.com\/wp-content\/uploads\/2025\/09\/2500x1406_FT_VitalistBay_02_opener.jpg?resize=1200,630\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Our ancient dream of a longer life is within reach, but we'll need the world\u2019s help to seize it.\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The longevity movement is growing \u2014 but it needs to go global","description":"Progress in longevity is real, but experts say the field needs government funding, policy reform, and public buy-in to reach its potential.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement","og_locale":"en_US","og_type":"article","og_title":"The longevity movement is growing \u2014 but it needs to go global","og_description":"Progress in longevity is real, but experts say the field needs government funding, policy reform, and public buy-in to reach its potential.","og_url":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement","og_site_name":"Freethink","article_modified_time":"2025-10-01T18:27:38+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.freethink.com\/wp-content\/uploads\/2025\/09\/2500x1406_FT_VitalistBay_02_opener.jpg?resize=1200,630","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_description":"Our ancient dream of a longer life is within reach, but we'll need the world\u2019s help to seize it.","twitter_misc":{"Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#article","isPartOf":{"@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement"},"author":{"name":"kristinhouser","@id":"https:\/\/www.freethink.com\/#\/schema\/person\/e45bf79276f6c14454ee4e1dfa7aca8c"},"headline":"The longevity movement is growing \u2014 but it needs to go global","datePublished":"2025-10-01T16:00:00+00:00","dateModified":"2025-10-01T18:27:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement"},"wordCount":2464,"publisher":{"@id":"https:\/\/www.freethink.com\/#organization"},"image":{"@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#primaryimage"},"thumbnailUrl":"https:\/\/www.freethink.com\/wp-content\/uploads\/2025\/09\/2500x1406_FT_VitalistBay_02_opener.jpg?quality=75","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement","url":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement","name":"The longevity movement is growing \u2014 but it needs to go global","isPartOf":{"@id":"https:\/\/www.freethink.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#primaryimage"},"image":{"@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#primaryimage"},"thumbnailUrl":"https:\/\/www.freethink.com\/wp-content\/uploads\/2025\/09\/2500x1406_FT_VitalistBay_02_opener.jpg?quality=75","datePublished":"2025-10-01T16:00:00+00:00","dateModified":"2025-10-01T18:27:38+00:00","description":"Progress in longevity is real, but experts say the field needs government funding, policy reform, and public buy-in to reach its potential.","breadcrumb":{"@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.freethink.com\/biotech\/the-longevity-movement"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#primaryimage","url":"https:\/\/www.freethink.com\/wp-content\/uploads\/2025\/09\/2500x1406_FT_VitalistBay_02_opener.jpg?quality=75","contentUrl":"https:\/\/www.freethink.com\/wp-content\/uploads\/2025\/09\/2500x1406_FT_VitalistBay_02_opener.jpg?quality=75","width":2500,"height":1406,"caption":"Samuli Hartikainen \/ Vitalist Bay"},{"@type":"BreadcrumbList","@id":"https:\/\/www.freethink.com\/biotech\/the-longevity-movement#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Articles","item":"https:\/\/www.freethink.com\/articles"},{"@type":"ListItem","position":2,"name":"The longevity movement is growing \u2014 but it needs to go global"}]},{"@type":"WebSite","@id":"https:\/\/www.freethink.com\/#website","url":"https:\/\/www.freethink.com\/","name":"Freethink","description":"Move the world","publisher":{"@id":"https:\/\/www.freethink.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.freethink.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.freethink.com\/#organization","name":"Freethink Media","url":"https:\/\/www.freethink.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.freethink.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.freethink.com\/wp-content\/uploads\/2021\/06\/logo.svg","contentUrl":"https:\/\/www.freethink.com\/wp-content\/uploads\/2021\/06\/logo.svg","width":651,"height":124,"caption":"Freethink Media"},"image":{"@id":"https:\/\/www.freethink.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.freethink.com\/#\/schema\/person\/e45bf79276f6c14454ee4e1dfa7aca8c","name":"kristinhouser","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.freethink.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff88759e0ed195de655c7703310050f17b921ae4fc276d7eb5930cddafa694f9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff88759e0ed195de655c7703310050f17b921ae4fc276d7eb5930cddafa694f9?s=96&d=mm&r=g","caption":"kristinhouser"},"url":"https:\/\/www.freethink.com\/author\/kristinhouser"}]}},"jetpack_sharing_enabled":true,"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/ftm_article\/116690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/ftm_article"}],"about":[{"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/types\/ftm_article"}],"author":[{"embeddable":true,"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/users\/25"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/media\/116775"}],"wp:attachment":[{"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/media?parent=116690"}],"wp:term":[{"taxonomy":"ftm_taxonomy_fields","embeddable":true,"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/ftm_taxonomy_fields?post=116690"},{"taxonomy":"ftm_taxonomy_challenges","embeddable":true,"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/ftm_taxonomy_challenges?post=116690"},{"taxonomy":"ftm_taxonomy_statuses","embeddable":true,"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/ftm_taxonomy_statuses?post=116690"},{"taxonomy":"ftm_taxonomy_hidden_tags","embeddable":true,"href":"https:\/\/www.freethink.com\/wp-json\/wp\/v2\/ftm_taxonomy_hidden_tags?post=116690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}